Table 2. Outcomes following treatment of SNMM with systemic immunotherapy and surgical resection at the primary site.

Pt.	Initial treatment	Response to immunotherapy		Resection after immunotherapy	Recurrence after immunotherapy and surgery	Survival (mo)
		Primary site	Distant sites
1	Surgery	Progression	Response (hepatic)	Subtotal	Distant	135
2	Surgery	Progression	Progression (pulmonary, intracranial, and hepatic)	Gross total	Local, distant	16
3	Immunotherapy	Progression	Stability (adrenal)	Gross total	None	20 a
4	Surgery	Progression	Response (osseous, soft tissue, and pulmonary)	Gross total	Distant	37

Abbreviations: Pt, patient; SNMM, sinonasal mucosal melanoma.

^aSurvival to date.